ORMP Oramed Pharmaceuticals Inc. - Common Stock
$4,76
Cena · Sie 24, 2026
Dane fundamentalne na dzień Sie 10, 2026
Zakres 52 tyg.
$2–$5
86% of range
Ocena Analityków
HOLD
6 analysts
Cena Docelowa
$6
+31% upside
P/E (TTM)
0.0
ROE
37.0%
Marża Zysku Netto
3202.5%
O Oramed Pharmaceuticals Inc. - Common Stock Przegląd firmy z Wikipedii
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.
Czytaj więcej
Oramed Pharmaceuticals Inc. (Hebrew: אורמד), is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.
History
Oramed Pharmaceuticals was founded in 2006 by Miriam Kidron, a scientist at the Hadassah University Hospital in Jerusalem, and her son Nadav Kidron.
Product pipeline
Oramed considers its flagship product to be an oral insulin capsule developed to treat sufferers of type 2 diabetes. The Company is currently conducting Phase 3 trials, under the FDA, for oral insulin in Type 2 diabetes.
In addition to the oral insulin capsule, Oramed is developing an exenatide-based capsule designed to balance blood sugar levels and control appetite, and is conducting clinical trials for the treatment of NASH with oral insulin.
In 2021, Oramed created a subsidiary, Oravax Medical, to bring an oral Covid-19 vaccine to market.
In January 2023, a Phase 3 trial of Oramed's orally administered insulin for Type 2 diabetes patients failed, thus causing the share price to plunge. The company has mentioned that the pill worked for a subset of the population and will pursue a Phase 3 trial for that subset.
In May 2023, Ben Shapiro invested $4.7 million and was named to the board of directors.
On May 15, 2023, it was reported that Oramed's insulin pill was approved in China and will work with a Chinese firm to apply for marketing authorizations.
Subsidiaries
OraTech Pharmaceuticals is a joint venture formed by Oramed Pharmaceuticals and Hefei Tianhui Biotech, to commercialize its insulin capsule and is expected to list on the NASDAQ sometime in 2025.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
ORMP Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$4.76
Kapitalizacja Rynkowa
$194.8K
P/E (TTM)
0.0
EPS (TTM)
$1.50
Przychody (TTM)
$2M
Stopa dywidendy
—
ROE
37.0%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$2 – $5
ORMP Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$2M
2017-08-31
→
2025-12-31
EPS
$1.50
2022-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-9M
2019-08-31
→
2025-12-31
Marże
3202.5%
2025-12-31
→
2025-12-31
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
ORMP
Mediana porównawcza
P/E (TTM)
0.0
23.4
P/S (TTM)
0.1
11.2
P/B
0.0
2.5
Price / FCF (Cena / FCF)
-0.0
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
ORMP
Mediana porównawcza
Gross Margin (Marża brutto)
0.65%
82.8%
Operating Margin (Marża Operacyjna)
-754.4%
—
Net Profit Margin (Marża Zysku Netto)
3202.5%
-199.7%
ROA
33.2%
-34.8%
ROE
37.0%
-33.2%
ROIC
-6.4%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
ORMP
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
7.0
1.5
Quick Ratio (Wskaźnik Szybkości)
2.7
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
ORMP
Mediana porównawcza
Revenue YoY (Przychody R/R)
-50.4%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
-9.6%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
ORMP
Mediana porównawcza
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
Stopa Dywidendy
—
Wskaźnik Wypłaty Dywidendy
—
CAGR dywidendy 5-letni
—
| Data ex-dywidendy | Kwota |
|---|---|
| 16 stycznia 2026 | $0,2500 |
ORMP Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
SPRZEDAJ
6 analityków
- Mocne kupno 0 0,0%
- Kup 0 0,0%
- Trzymaj 3 50,0%
- Sprzedaj 1 16,7%
- Mocna sprzedaż 2 33,3%
12-miesięczny cel cenowy
1 analityków · 2026-08-24
Niski
$6.25
Wysoki
$6.25
Średni cel
$6.25
+31,3%
Średnia cel
$6.25
+31,3%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.32%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 grudnia 2025 | $0.24 | $0.00 | 0.24% |
| 30 września 2025 | $1.12 | $-0.04 | 1.2% |
| 30 czerwca 2025 | $0.31 | $-0.04 | 0.35% |
| 31 marca 2025 | $-0.19 | $-0.01 | -0.18% |
| 31 grudnia 2024 | $0.00 | $-0.03 | 0.03% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| ORMP | $112M | 1.9 | -50.4% | 3202.5% | 37.0% | 0.65% |
| DERM | — | -16.4 | 10.2% | -18.5% | -44.7% | — |
| SIGA | $438M | 19.1 | -31.8% | 24.6% | 11.4% | — |
| ANTX | $31M | -1.0 | — | — | -57.7% | — |
| NRXP | — | — | — | — | — | — |
| AARD | $286M | -4.5 | — | — | -47.3% | — |
| LENZ | $502M | -5.6 | — | -430.2% | -33.5% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | · | $1M | $3M | · | $3M | $3M | $2M | $2M | |
| Cost of Revenue | $2M | · | · | · | · | · | $90.0K | $-86.0K | $187.0K | |
| Gross Profit | $13.0K | · | · | · | · | · | · | · | · | |
| R&D Expense | $6M | $6M | $9M | $28M | · | $10M | $14M | $12M | $10M | |
| SG&A Expense | $9M | $6M | $8M | $14M | · | $4M | $4M | $4M | $3M | |
| Operating Income | $-15M | $-13M | $-16M | $-41M | · | $-12M | $-15M | $-14M | $-11M | |
| Interest Expense | · | · | $2M | · | · | · | · | · | · | |
| Interest Income | · | · | $10.0K | · | · | · | · | · | · | |
| Other Non-op | $-606.0K | $-27.0K | $13.3K | $3M | · | · | · | · | · | |
| Pretax Income | $75M | $-16M | $5M | $-38M | · | $-12M | $-14M | $-13M | $-10M | |
| Income Tax | $11M | $3M | · | $100.0K | · | · | $300.0K | · | $400.0K | |
| Net Income | $64M | $-19M | $5M | $-37M | · | $-12M | $-14M | $-13M | $-10M | |
| EPS (Basic) | $1.53 | $-0.48 | $0.14 | $-0.94 | · | · | · | · | · | |
| EPS (Diluted) | $1.50 | $-0.48 | $0.14 | $-0.94 | · | · | · | · | · | |
| Shares (Basic) | 41,402,997 | 40,850,446 | 40,315,068 | 38,997,649 | · | · | · | · | · | |
| Shares (Diluted) | 42,418,644 | 40,850,446 | 40,566,901 | 38,997,649 | · | · | · | · | · | |
| EBITDA | $-15M | · | $-16M | $-41M | · | $-12M | $-15M | · | · |
Bilans 23
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $54M | $9M | $40M | · | $19M | $3M | $5M | $4M | |
| Short-term Investments | $5M | $3M | · | · | $8M | $3M | · | $5M | · | |
| Prepaid Expense | $3M | $1M | $537.0K | $1M | · | $611.0K | $1M | $574.0K | · | |
| Current Assets | $133M | $143M | $163M | $157M | $148M | $41M | $33M | $31M | · | |
| PP&E (Net) | $586.0K | $698.0K | $873.0K | $815.0K | $388.0K | $99.0K | $24.0K | $17.0K | · | |
| Other Non-current Assets | $44.0K | $32.0K | $27.0K | · | · | · | · | · | · | |
| Total Assets | $231M | $155M | $221M | $162M | $178M | $45M | $35M | $47M | · | |
| Accounts Payable | $443.0K | $789.0K | $551.0K | $4M | $5M | $2M | $3M | $2M | · | |
| Accrued Liabilities | $1M | $402.0K | $605.0K | · | · | · | · | · | · | |
| Short-term Debt | $652.0K | $329.0K | $51M | · | · | · | $3M | $2M | · | |
| Current Liabilities | $19M | $6M | $53M | $6M | $7M | $5M | $5M | $5M | · | |
| Capital Leases | $540.0K | $156.0K | $342.0K | $647.0K | $370.0K | $31.0K | · | · | · | |
| Deferred Tax | $8M | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | $60.0K | $63.0K | · | · | $211.0K | $271.0K | $313.0K | · | |
| Long-term Debt | · | · | · | $25.0K | $12M | · | $10M | $11M | · | |
| Total Debt | · | · | $51M | · | · | · | $3M | · | · | |
| Common Stock | $472.0K | $480.0K | $485.0K | $476.0K | $459.0K | $284.0K | $208.0K | $207.0K | · | |
| Paid-in Capital | · | · | · | $314M | $293M | $125M | · | · | · | |
| Retained Earnings | $-123M | $-177M | $-158M | $-163M | $-127M | $-93M | $-81M | $-69M | · | |
| AOCI | · | · | · | · | · | · | · | $702.0K | · | |
| Stockholders' Equity | $200M | $145M | $164M | $152M | $166M | $33M | $19M | $31M | $19M | |
| Liabilities + Equity | $231M | $155M | $221M | $162M | $178M | $45M | $35M | $47M | · | |
| Shares Outstanding | 39,275,006 | 39,920 | 40,339,000 | 39,564,000 | 38,158 | 23,675,530 | 17,383,359 | 17,369,875 | · |
Przepływy pieniężne 12
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $4M | $4M | $12M | · | $465.0K | $808.0K | $2M | $2M | |
| Deferred Tax | $8M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-8M | $-10M | $-28M | · | $-12M | $-13M | $-15M | $-6M | |
| CapEx | $9.0K | $18.0K | $254.0K | $496.0K | · | $82.0K | $15.0K | $5.0K | $7.0K | |
| Investing Cash Flow | $5M | $106M | $-73M | $30M | · | $5M | $11M | $-7M | $4M | |
| Stock Issued | · | · | $2M | $12M | · | · | · | · | · | |
| Stock Repurchased | $5M | $2M | · | · | · | · | · | · | · | |
| Net Stock Activity | $-5M | · | $2M | $11M | · | · | · | · | · | |
| Financing Cash Flow | $-5M | $-52M | $52M | $11M | · | $24M | · | $23M | $2M | |
| Net Change in Cash | $-8M | $45M | $-31M | $13M | · | $16M | $-2M | $1M | $62.0K | |
| Taxes Paid | · | $2M | · | $2M | · | · | $300.0K | · | $400.0K | |
| Free Cash Flow | $-9M | · | $-11M | $-28M | · | $-13M | $-13M | · | · |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 0.65% | · | · | · | · | · | · | · | · | |
| Operating Margin | -754.4% | · | -1176.8% | -1502.0% | · | -433.8% | -541.3% | · | · | |
| Net Margin | 3202.5% | · | 412.3% | -1397.1% | · | -424.8% | -531.1% | · | · | |
| Pretax Margin | 3766.2% | · | 379.7% | · | · | -424.8% | -520.0% | · | · | |
| EBITDA Margin | -754.4% | · | -1176.8% | -1502.0% | · | -433.8% | -541.3% | · | · | |
| ROA | 33.2% | · | 2.9% | -22.2% | · | -29.0% | -35.0% | · | · | |
| ROE | 37.0% | · | 3.5% | -23.7% | · | -47.0% | -70.1% | · | · | |
| ROIC | -6.4% | · | · | · | · | · | -67.6% | · | · |
Płynność i wypłacalność 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | · | 3.1 | 27.3 | · | 8.9 | 6.3 | · | · | |
| Quick Ratio | 2.7 | · | 1.3 | 0.7 | · | 5.0 | 1.3 | · | · | |
| Debt / Equity | · | · | 0.3 | · | · | · | 0.1 | · | · | |
| Interest Coverage | · | · | -7.7 | · | · | · | · | · | · |
Efektywność 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | · | 0.1 | 0.1 | · | · |
Stopy Wzrostu 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -50.4% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -9.6% | · | · | · | · | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $3M | $1M | $3M | · | $3M | $3M | $2M | $2M | |
| Net Income TTM | $64M | $-19M | $5M | $-37M | · | $-12M | $-14M | $-13M | $-10M | |
| Market Cap | $112M | · | $93M | $476M | · | $83M | $58M | · | · | |
| Enterprise Value | · | · | $77M | · | · | · | $53M | · | · | |
| P/E | 1.9 | -5.0 | 16.5 | -12.8 | · | · | · | · | · | |
| P/S | 56.0 | · | 69.5 | 176.1 | · | 30.5 | 21.4 | · | · | |
| P/B | 0.6 | · | 0.6 | 3.1 | · | 2.5 | 3.0 | · | · | |
| P / Tangible Book | 0.6 | 0.7 | 0.6 | 3.1 | · | 2.5 | · | · | · | |
| P / Cash Flow | -12.2 | · | -9.1 | -17.0 | · | -6.6 | -4.5 | · | · | |
| P / FCF | -12.2 | · | -8.8 | -16.8 | · | -6.6 | -4.5 | · | · | |
| EV / EBITDA | · | · | -4.9 | · | · | · | -3.6 | · | · | |
| EV / FCF | · | · | -7.3 | · | · | · | -4.1 | · | · | |
| EV / Revenue | · | · | 57.8 | · | · | · | 19.8 | · | · | |
| Earnings Yield | 52.6% | -19.8% | 6.1% | -7.8% | · | · | · | · | · |
Rachunek zysków i strat 17
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | · | · | $2M | · | · | · | · | $0 | · | $674.0K | $666.0K | $681.0K | $682.0K | |
| Cost of Revenue | · | · | $0 | · | · | $2M | · | · | · | · | · | · | · | · | · | · | |
| Gross Profit | · | · | $0 | · | · | $13.0K | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | · | $2M | $2M | $1M | $1M | $2M | $1M | $2M | $1M | $1M | $2M | $957.0K | $2M | $4M | $7M | $5M | |
| SG&A Expense | $3M | $2M | $4M | $1M | $1M | $2M | $2M | $847.0K | $2M | $2M | $2M | $3M | $2M | $1M | $3M | $3M | |
| Operating Expenses | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $11.0K | |
| Operating Income | $-3M | $-4M | $-6M | $-2M | $-2M | $-4M | $-4M | $-3M | $-3M | $-3M | $-4M | $-3M | $-4M | $-5M | $-10M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $592.0K | · | $826.0K | · | · | · | · | |
| Other Non-op | $-4.0K | $-100.0K | $-74M | $61M | · | $-143.0K | $-2M | $-15M | $14M | $4M | $-4M | $435.0K | $2M | $2M | $1M | $1M | |
| Pretax Income | $102M | $49M | $10M | $59M | $13M | $-7M | $-10M | $-19M | $11M | $2M | $13M | $-3M | $-1M | · | $-9M | $-7M | |
| Income Tax | $23M | $11M | $-212.0K | $11M | $-126.0K | $584.0K | $416.0K | $1M | $2M | · | · | · | · | · | $0 | $100.0K | |
| Net Income | $78M | $38M | $10M | $48M | $13M | $-8M | $-10M | $-20M | $9M | $2M | $13M | $-3M | $-1M | $-3M | $-8M | $-7M | |
| EPS (Basic) | $1.90 | $0.94 | $0.24 | $1.16 | $0.32 | $-0.19 | $-0.26 | $-0.48 | $0.22 | $0.04 | $0.33 | $-0.08 | $-0.03 | $-0.08 | $-1.66 | $0.18 | |
| EPS (Diluted) | $1.84 | $0.91 | $0.25 | $1.13 | $0.31 | $-0.19 | $-0.26 | $-0.48 | $0.22 | $0.04 | $0.33 | $-0.08 | $-0.03 | $-0.08 | $-1.66 | $0.18 | |
| Shares (Basic) | 41,040,479 | 40,773,866 | -83,325,572 | 41,756,301 | 41,743,486 | 41,228,782 | -81,842,111 | 40,896,845 | 40,959,759 | 40,835,953 | -80,397,680 | 40,445,896 | 40,225,594 | 40,041,258 | -77,577,522 | 39,100,231 | |
| Shares (Diluted) | 42,501,252 | 41,970,186 | -84,194,067 | 42,774,504 | 42,609,425 | 41,228,782 | -83,201,413 | 40,896,845 | 41,591,007 | 41,564,007 | -80,145,847 | 40,445,896 | 40,225,594 | 40,041,258 | -77,577,522 | 39,100,231 | |
| EBITDA | $-3M | $-4M | · | $-2M | $-2M | $-4M | · | $-3M | $-3M | $-3M | · | $-3M | $-4M | $-5M | · | $-8M |
Bilans 22
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15M | $13M | $46M | $52M | $16M | · | $54M | · | $10M | $19M | · | · | · | · | $40M | · | |
| Short-term Investments | $846.0K | $5M | $5M | $5M | $2M | $4M | $3M | $57M | $66M | $78M | · | $49.4K | $943.0K | $2M | · | $5M | |
| Prepaid Expense | $2M | $2M | $3M | $1M | $1M | $832.0K | $1M | $474.0K | $533.0K | $501.0K | $537.0K | $666.0K | $769.0K | · | $1M | · | |
| Current Assets | $53M | $68M | $133M | $136M | $99M | $131M | $143M | $143M | $153M | $177M | $163M | $176M | $151M | $155M | $157M | $160M | |
| PP&E (Net) | $532.0K | $561.0K | $586.0K | $614.0K | $645.0K | $671.0K | $698.0K | $718.0K | $765.0K | $819.0K | $873.0K | $923.0K | $945.0K | $977.0K | $815.0K | $535.0K | |
| Other Non-current Assets | $49.0K | $46.0K | $44.0K | $40.0K | $38.0K | $32.0K | $32.0K | · | · | · | $27.0K | · | · | · | · | · | |
| Total Assets | $370M | $269M | $231M | $220M | $162M | $148M | $155M | $165M | $184M | $204M | $221M | $231M | $156M | $160M | $162M | $164M | |
| Accounts Payable | $374.0K | $481.0K | $443.0K | $560.0K | $715.0K | $509.0K | $789.0K | $5M | $3M | $1M | $551.0K | $3M | $828.0K | $4M | $4M | $4M | |
| Accrued Liabilities | $1M | $1M | $1M | $585.0K | $841.0K | $800.0K | $402.0K | · | · | · | $605.0K | · | · | · | · | · | |
| Short-term Debt | · | · | · | $1.0K | $34.0K | $36.0K | · | · | · | $32M | $51M | $75M | $3.0K | $1.0K | · | · | |
| Current Liabilities | $11M | $11M | $19M | $6M | $4M | $5M | $6M | $5M | $4M | $34M | $53M | $78M | $1M | $5M | $6M | $7M | |
| Capital Leases | $484.0K | $493.0K | $540.0K | $589.0K | $648.0K | $120.0K | $156.0K | $186.0K | $236.0K | $272.0K | $342.0K | $389.0K | $488.0K | $564.0K | $647.0K | $672.0K | |
| Deferred Tax | $40M | $18M | $8M | $8M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | $60.0K | $60.0K | $60.0K | · | $63.0K | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $75M | · | · | · | $5M | |
| Total Debt | · | · | · | $1.0K | $34.0K | $36.0K | · | · | · | $32M | · | $75M | $3.0K | $1.0K | · | · | |
| Common Stock | $495.0K | $491.0K | $472.0K | $490.0K | $491.0K | $491.0K | $480.0K | $484.0K | $488.0K | $487.0K | $485.0K | $484.0K | $484.0K | $481.0K | $476.0K | $470.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | · | $319M | $317M | · | $308M | |
| Retained Earnings | $-7M | $-85M | $-123M | $-123M | $-171M | $-184M | $-177M | $-166M | $-147M | $-156M | $-158M | $-171M | $-168M | $-166M | $-163M | $-155M | |
| Stockholders' Equity | $317M | $238M | $200M | $203M | $155M | $141M | $146M | $156M | $177M | $167M | $164M | $149M | $152M | $151M | $152M | $154M | |
| Liabilities + Equity | $370M | $269M | $231M | $220M | $162M | $148M | $155M | $165M | $184M | $204M | $221M | $231M | $156M | $160M | $162M | $164M | |
| Shares Outstanding | 41,314,211 | 40,926,081 | 39,275,006 | 40,838,226 | 40,845,087 | 40,850,455 | 39,919,545 | 40,209,575 | 40,628,924 | 40,519,160 | 40,338,979 | 40,282,688 | 40,219,396 | 39,969,979 | 39,563,888 | 39,113,236 |
Przepływy pieniężne 12
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $2M | $2M | $719.0K | $800.0K | $2M | $1M | $301.0K | $1M | $1M | $1M | $852.0K | $2M | $173.0K | $3M | $3M | |
| Deferred Tax | $22M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-200.0K | $-3M | $-466.0K | $-2M | $-4M | $-4M | $-2M | $-7M | $2M | $-1M | $-1M | $-694.0K | $-3M | $-6M | $-8M | $-2M | |
| CapEx | $2.0K | $5.0K | $2.0K | $0 | $4.0K | $3.0K | $11.0K | $5.0K | $0 | $2.0K | $3.0K | $32.0K | $20.0K | $199.0K | $308.0K | $121.0K | |
| Investing Cash Flow | $4M | $-19M | $-2M | $38M | $-55M | $24M | $15M | $-34M | $95M | $30M | $30M | $-75M | $-15M | $-13M | $11M | $1M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $-2.0K | $0 | $2M | $4M | $-3M | |
| Stock Repurchased | · | · | $4M | $361.0K | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $78.0K | $10M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-2M | $-10M | $-4M | $-361.0K | · | · | $-1M | $-1M | $-31M | $-19M | $-25M | $75M | $0 | $2M | $4M | $4M | |
| Net Change in Cash | $2M | $-33M | $-6M | $36M | $-59M | $20M | $12M | $-43M | $66M | $10M | $4M | $-1M | $-17M | $-16M | $7M | $3M | |
| Taxes Paid | · | · | · | $-7M | · | · | · | · | · | · | · | $527.0K | $3M | $308.0K | · | $167.0K | |
| Free Cash Flow | · | $-3M | · | · | · | $-4M | · | · | · | $-1M | · | · | · | $-6M | · | · |
Rentowność 8
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 0.65% | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | · | · | · | · | · | -225.0% | · | · | · | · | · | · | -562.5% | -782.0% | · | -1200.7% | |
| Net Margin | · | · | · | · | · | -382.1% | · | · | · | · | · | · | -177.2% | -542.2% | · | -1063.5% | |
| Pretax Margin | · | · | · | · | · | -352.9% | · | · | · | · | · | · | · | · | · | -1048.8% | |
| EBITDA Margin | · | · | · | · | · | -225.0% | · | · | · | · | · | · | -562.5% | -782.0% | · | -1200.7% | |
| ROA | 29.4% | 18.4% | · | 25.1% | 7.7% | -4.3% | · | -9.9% | 5.4% | 0.85% | · | -1.6% | -0.75% | -2.2% | · | -5.9% | |
| ROE | 33.1% | 20.2% | · | 26.9% | 8.0% | -5.0% | · | -12.8% | 5.6% | 0.97% | · | -2.1% | -0.78% | -2.3% | · | -6.5% | |
| ROIC | -0.67% | -1.2% | · | -0.97% | -1.6% | -3.5% | · | -2.1% | -1.5% | · | · | · | · | · | · | -5.4% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 6.5 | · | 22.2 | 26.8 | 23.9 | · | 27.1 | 41.1 | 5.3 | · | 2.2 | 141.5 | 31.2 | · | 24.5 | |
| Quick Ratio | 1.5 | 1.7 | · | 9.3 | 4.8 | 0.7 | · | 10.9 | 20.4 | 2.9 | · | 0.0 | 0.9 | 0.5 | · | 0.8 | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | · | · | 0.2 | · | 0.5 | 0.0 | 0.0 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -5.0 | · | -3.5 | · | · | · | · |
Efektywność 1
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | · | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 |
Wycena (TTM) 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Net Income TTM | $178M | $92M | · | $34M | $-5M | $-17M | · | $-12M | $6M | $-6M | · | $-15M | $-22M | $-32M | · | $-36M | |
| Market Cap | $199M | $139M | · | $108M | $92M | $87M | · | $98M | $104M | $118M | · | $105M | $144M | $87M | · | $253M | |
| Enterprise Value | · | · | · | $51M | $74M | · | · | · | · | $54M | · | · | · | · | · | · | |
| P/E | 1.1 | 1.6 | · | 3.4 | -16.1 | -5.2 | · | -8.1 | 17.1 | -19.5 | · | -261.0 | 10.5 | 3.4 | · | 7.0 | |
| P/S | · | · | · | · | · | · | · | 36.4 | 38.7 | 43.9 | · | 39.0 | 53.4 | 32.4 | · | 94.0 | |
| P/B | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 1.0 | 0.6 | · | 1.6 | |
| P / Tangible Book | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 1.0 | 0.6 | · | 1.6 | |
| P / Cash Flow | · | -47.7 | · | · | · | -24.8 | · | · | · | -80.2 | · | · | · | -15.7 | · | · | |
| P / FCF | · | -47.7 | · | · | · | -24.8 | · | · | · | -80.1 | · | · | · | -15.2 | · | · | |
| EV / EBITDA | · | · | · | -20.9 | -29.9 | · | · | · | · | -18.2 | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | · | · | · | · | -36.6 | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | 20.0 | · | · | · | · | · | · | |
| Earnings Yield | 87.1% | 63.5% | · | 29.2% | -6.2% | -19.2% | · | -12.3% | 5.8% | -5.1% | · | -0.38% | 9.5% | 29.4% | · | 14.3% | |
| Payout Ratio | · | 27.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $2M | — | $1M | $3M | — |
| Marża Brutto % | 0.65% | — | — | — | — |
| Marża Operacyjna % | -754.4% | — | -1176.8% | -1502.0% | — |
| Zysk netto | $64M | $-19M | $5M | $-37M | — |
| Rozwodniony EPS | $1.50 | $-0.48 | $0.14 | $-0.94 | — |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | — | — | 0.3 | — | — |
| Wskaźnik bieżący | 7.0 | — | 3.1 | 27.3 | — |
| Wskaźnik Szybkości | 2.7 | — | 1.3 | 0.7 | — |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-9M | — | $-11M | $-28M | — |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 88 emitentów · $73.5M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 30 (+13 vs poprzedni kw.) | 8 (0 vs poprzedni kw.) | 20 (0 vs poprzedni kw.) | 19 (+5 vs poprzedni kw.) | +1.7M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| MERCER GLOBAL ADVISORS INC /ADV | $18 328 697 | 3 810 540 | 24,94% | Akcje |
| Aquamarine Financial (Cayman) Ltd | $12 083 562 | 2 512 175 | 16,44% | Akcje |
| Gem Investment Advisors, LLC | $9 614 238 | 1 998 802 | 13,08% | Akcje |
| Murchinson Ltd. | $6 206 314 | 1 290 294 | 8,44% | Akcje |
| SB Capital Management Inc | $5 415 000 | 1 900 000 | 7,37% | Akcje |
| BML Capital Management, LLC | $4 166 754 | 866 269 | 5,67% | Akcje |
| BOOTHBAY FUND MANAGEMENT, LLC | $2 783 249 | 578 638 | 3,79% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $2 162 008 | 449 482 | 2,94% | Akcje |
| STATE STREET CORP | $1 164 501 | 242 100 | 1,58% | Akcje |
| Rathbones Group PLC | $1 120 816 | 233 018 | 1,52% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 105 732 | 229 882 | 1,50% | Akcje |
| GOLDMAN SACHS GROUP INC | $950 908 | 197 694 | 1,29% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $884 078 | 183 800 | 1,20% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $784 896 | 163 180 | 1,07% | Akcje |
| STRS OHIO | $643 578 | 133 800 | 0,88% | Akcje |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $495 247 | 102 962 | 0,67% | Akcje |
| JANE STREET GROUP, LLC | $470 606 | 97 839 | 0,64% | Akcje |
| Hillsdale Investment Management Inc. | $429 533 | 89 300 | 0,58% | Akcje |
| RITHOLTZ WEALTH MANAGEMENT | $405 709 | 84 347 | 0,55% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $402 280 | 83 634 | 0,55% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $287 518 | 59 775 | 0,39% | Akcje |
| XTX Topco Ltd | $240 130 | 49 923 | 0,33% | Akcje |
| Nuveen, LLC | $223 203 | 46 404 | 0,30% | Akcje |
| DEUTSCHE BANK AG\ | $159 682 | 33 198 | 0,22% | Akcje |
| PRELUDE CAPITAL MANAGEMENT, LLC | $157 350 | 32 713 | 0,21% | Akcje |
| BAILARD, INC. | $156 219 | 32 478 | 0,21% | Akcje |
| RHUMBLINE ADVISERS | $147 281 | 30 621 | 0,20% | Akcje |
| Bank of New York Mellon Corp | $143 016 | 29 733 | 0,19% | Akcje |
| ALGERT GLOBAL LLC | $139 288 | 28 958 | 0,19% | Akcje |
| WELLS FARGO & COMPANY/MN | $137 080 | 28 499 | 0,19% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $121 246 | 25 207 | 0,16% | Akcje |
| CITADEL ADVISORS LLC | $120 250 | 25 000 | 0,16% | Opcja kupna |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $107 263 | 22 300 | 0,15% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $105 151 | 21 861 | 0,14% | Akcje |
| PNC Financial Services Group, Inc. | $101 972 | 21 200 | 0,14% | Akcje |
| Redwood Family Wealth LLC | $99 783 | 20 745 | 0,14% | Akcje |
| BANK OF AMERICA CORP /DE/ | $91 621 | 19 048 | 0,12% | Akcje |
| MORGAN STANLEY | $87 994 | 18 294 | 0,12% | Akcje |
| Sage Capital Management, LLC | $86 474 | 17 977 | 0,12% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $75 378 | 15 671 | 0,10% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $67 811 | 14 098 | 0,09% | Akcje |
| CITIGROUP INC | $66 590 | 13 844 | 0,09% | Akcje |
| JPMORGAN CHASE & CO | $65 461 | 14 108 | 0,09% | Akcje |
| Invesco Ltd. | $65 272 | 13 570 | 0,09% | Akcje |
| Y-Intercept (Hong Kong) Ltd | $61 650 | 12 817 | 0,08% | Akcje |
| Engineers Gate Manager LP | $61 077 | 12 698 | 0,08% | Akcje |
| Altshuler Shaham Ltd | $53 925 | 11 211 | 0,07% | Akcje |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $52 096 | 12 895 | 0,07% | Akcje |
| Glass Jacobson Investment Advisors llc | $50 698 | 10 540 | 0,07% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $50 115 | 10 419 | 0,07% | Akcje |
| MARSHALL WACE, LLP | $50 024 | 10 400 | 0,07% | Akcje |
| Hudson Bay Capital Management LP | $49 375 | 10 265 | 0,07% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $47 706 | 9 918 | 0,06% | Akcje |
| Steward Partners Investment Advisory, LLC | $42 453 | 8 826 | 0,06% | Akcje |
| BARCLAYS PLC | $27 917 | 5 804 | 0,04% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $25 974 | 5 400 | 0,04% | Akcje |
| NORTHERN TRUST CORP | $25 503 | 5 302 | 0,03% | Akcje |
| Tower Research Capital LLC (TRC) | $23 218 | 4 827 | 0,03% | Akcje |
| OSAIC HOLDINGS, INC. | $20 283 | 4 217 | 0,03% | Akcje |
| FEDERATED HERMES, INC. | $19 221 | 3 996 | 0,03% | Akcje |
| N.E.W. Advisory Services LLC | $16 495 | 3 429 | 0,02% | Akcje |
| Legal & General Group Plc | $15 979 | 3 322 | 0,02% | Akcje |
| CITADEL ADVISORS LLC | $15 565 | 3 236 | 0,02% | Akcje |
| Ameritas Investment Partners, Inc. | $14 853 | 3 088 | 0,02% | Akcje |
| HUNTINGTON NATIONAL BANK | $14 440 | 3 002 | 0,02% | Akcje |
| Pioneer Family Office, LLC | $14 430 | 3 000 | 0,02% | Akcje |
| Russell Investments Group, Ltd. | $13 088 | 2 721 | 0,02% | Akcje |
| UBS Group AG | $12 987 | 2 700 | 0,02% | Akcje |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $7 576 | 1 575 | 0,01% | Akcje |
| MetLife Investment Management, LLC | $7 037 | 1 463 | 0,01% | Akcje |
| BlackRock, Inc. | $6 768 | 1 407 | 0,01% | Akcje |
| ROYAL BANK OF CANADA | $6 000 | 1 246 | 0,01% | Akcje |
| MCF Advisors LLC | $5 162 | 1 073 | 0,01% | Akcje |
| Caitlin John, LLC | $4 810 | 1 000 | 0,01% | Akcje |
| McIlrath & Eck, LLC | $3 400 | 1 000 | 0,00% | Akcje |
| Sterling Capital Management LLC | $3 300 | 686 | 0,00% | Akcje |
| IFP Advisors, Inc | $2 405 | 500 | 0,00% | Akcje |
| PROEQUITIES, INC. | $2 310 | 1 000 | 0,00% | Akcje |
| Golden State Wealth Management, LLC | $1 458 | 303 | 0,00% | Akcje |
| JONES FINANCIAL COMPANIES LLLP | $999 | 214 | 0,00% | Akcje |
| HRT FINANCIAL LP | $469 | 97 582 | 0,00% | Akcje |
| FMR LLC | $332 | 69 | 0,00% | Akcje |
| SBI Securities Co., Ltd. | $284 | 59 | 0,00% | Akcje |
| PRICE T ROWE ASSOCIATES INC /MD/ | $135 | 27 909 | 0,00% | Akcje |
| TrinityBridge Ltd | $56 | 11 675 | 0,00% | Akcje |
| HARBOUR INVESTMENTS, INC. | $48 | 10 | 0,00% | Akcje |
| Caitong International Asset Management Co., Ltd | $29 | 6 | 0,00% | Akcje |
| ACADIAN ASSET MANAGEMENT LLC | $8 | 1 691 | 0,00% | Akcje |
Insiderzy spółki 30 insiderów · 13 dyrektorzy generalni · 16 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Nadav Kidron | President and CEO | 30 marca 2026 F | 3 422 243 | 0 | 0 | $0 |
| Avraham Gabay | Chief Financial Officer | 1 lipca 2026 S | 671 785 | 0 | 1 | $-330 854 |
| David Silberman | Chief Financial Officer | 4 stycznia 2024 A | 366 500 | 0 | 0 | $0 |
| Hilla Eisenberg | CFO, Treasurer and Secretary | 26 lutego 2019 A | — | 0 | 0 | $0 |
| Yifat Hen Zommer | CFO, Treasurer and Secretary | 30 czerwca 2017 A | 46 560 | 0 | 0 | $0 |
| Chaime Orlev | CFO, Treasurer and Secretary | 12 października 2008 A | — | 0 | 0 | $0 |
| Joshua Hexter | COO & CBO | 2 lipca 2026 M | 1 073 384 | 0 | 1 | $-611 020 |
| Miriam Kidron | Chief Scientific Officer | 30 marca 2026 F | 1 133 138 | 0 | 0 | $0 |
| Netanel Derovan | Chief Legal Officer | 26 maja 2023 A | 149 500 | 0 | 0 | $0 |
| Michael Rabinowitz | Chief Commercial Officer | 3 stycznia 2023 S | 126 143 | 0 | 0 | $0 |
| Michael Rabinowitz | Chief Commercial Officer | 3 stycznia 2022 A | 109 468 | 0 | 0 | $0 |
| Mark Daniel Hasleton | VP Business Development | 26 lutego 2019 A | — | 0 | 0 | $0 |
| Ronald Edward Law | Chief Strategy Officer | 20 marca 2017 A | — | 0 | 0 | $0 |
| Yehuda Reznick | Dyrektor | 31 grudnia 2025 A | 105 180 | 0 | 0 | $0 |
| Daniel Aghion | Dyrektor | 31 grudnia 2025 A | 113 441 | 0 | 0 | $0 |
| Benjamin Shapiro | Dyrektor | 31 grudnia 2025 A | 123 220 | 0 | 0 | $0 |
| Arie Mayer | Dyrektor | 31 grudnia 2025 A | 168 009 | 0 | 0 | $0 |
| Leonard Sank | Dyrektor | 5 czerwca 2025 A | 134 531 | 0 | 0 | $0 |
| Yadin Rozov | Dyrektor | 4 stycznia 2024 A | 155 320 | 0 | 0 | $0 |
| Kevin Rakin | Dyrektor | 21 marca 2022 S | 46 661 | 0 | 0 | $0 |
| Aviad Friedman | Dyrektor | 3 stycznia 2022 G | 0 | 0 | 0 | $0 |
| Gao Xiaoming | Dyrektor | 8 stycznia 2020 A | — | 0 | 0 | $0 |
| David Mark Slager | Dyrektor | 15 kwietnia 2019 A | 1 316 328 | 0 | 0 | $0 |
| Xiaopeng Li | Dyrektor | 2 sierpnia 2017 P | 206 350 | 0 | 0 | $0 |
| Harold Jacob | Dyrektor | 10 marca 2016 S | 16 396 | 0 | 0 | $0 |
| Michael Berelowitz | Dyrektor | 9 grudnia 2015 S | 22 896 | 0 | 0 | $0 |
| Gerald M Ostrov | Dyrektor | 23 lutego 2015 A | 24 896 | 0 | 0 | $0 |
| REGALS CAPITAL MANAGEMENT LP | Posiadacz 10% | 23 grudnia 2015 X | 1 186 823 | 0 | 0 | $0 |
| Zeev Bronfeld | Posiadacz 10% | 27 września 2011 S | 5 808 517 | 0 | 0 | $0 |
| Michael Young | — | 27 maja 2004 S | 0 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 9 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. | 22 lipca 2026 | 3,30% | Aneks | — | SEC |
| Nadav Kidron ×8 zgłoszenia | 28 sierpnia 2025 | 7,60% | Aneks | — | SEC |
| Regals Capital Management LP, Regals Fund LP, David M. Slager ×2 zgłoszenia | 20 lipca 2018 | — | Pierwotne zgłoszenie | — | SEC |
| Hefei Tianhui Incubator of Technologies Co., Ltd | 6 stycznia 2016 | — | Pierwotne zgłoszenie | — | SEC |
| Leonard Sank | 15 grudnia 2014 | — | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| Miriam Kidron ×2 zgłoszenia | 3 lutego 2014 | — | Pierwotne zgłoszenie | — | SEC |
| Zeev Bronfeld | 6 marca 2006 | — | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| Niezgłoszona osoba raportująca | 10 czerwca 2004 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca | 10 czerwca 2004 | — | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 14 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IWC · iShares Trust | 0,04% | 119 666 SH | 21 sierpnia 2026 | Dziennie |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 7 046 SH | 21 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | 0,01% | 316 411 SH | 21 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 29 637 SH | 19 sierpnia 2026 | Dziennie |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 28 155 NS | 31 maja 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 624 810 SH | 21 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,00% | 26 896 NS | 30 kwietnia 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4 523 NS | 30 kwietnia 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 36 536 NS | 30 kwietnia 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 4 152 NS | 31 maja 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 3 431 NS | 30 kwietnia 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 196 765 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 480 SH | 19 sierpnia 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,00% | 4 NS | 30 kwietnia 2026 | N-PORT |